SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-14-000060
Filing Date
2014-11-13
Accepted
2014-11-13 13:52:38
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES, INC. QUARTERLY REPORT quarterlyreport.htm 10-Q 510695
2 EXHIBIT 31.1 ex311.htm EX-31.1 15719
3 EXHIBIT 31.2 ex312.htm EX-31.2 15723
4 EXHIBIT 32.1 ex321.htm EX-32.1 6810
5 EXHIBIT 32.2 ex322.htm EX-32.2 6827
  Complete submission text file 0001513160-14-000060.txt   2104399

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpb-20140930.xml EX-101.INS 190019
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnpb-20140930.xsd EX-101.SCH 20603
8 XBRL TAXONOMY EXTENTION CALCULATION DOCUMENT gnpb-20140930_cal.xml EX-101.CAL 27374
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnpb-20140930_def.xml EX-101.DEF 47526
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnpb-20140930_lab.xml EX-101.LAB 149844
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnpb-20140930_pre.xml EX-101.PRE 109913
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53127 | Film No.: 141217637
SIC: 2836 Biological Products, (No Diagnostic Substances)